OMDAOmada Health, Inc.

$21.86-6.3% 1Y

The financials

Omada Health, Inc. by the numbers

Omada Health, Inc. (OMDA) reported revenue of $88M in Q2 2026 (quarter ended Jun 30, 2026), up 43% from the same quarter a year earlier. That came with a gross margin of 73% and net income of $5.3M (6.0% of revenue). For the full year FY2025, revenue was $260M (+53% year on year) and net income −$13M. Its largest product in Q2 2026 was Service at $81M, 92% of the disclosed total, well ahead of Hardware at 8.1%. The next results filing is expected around Nov 5, 2026, the same week as a year ago.

Omada Health, Inc. income statement, Q2 2026 against the same quarter a year earlier
Income statementQ2 2026Q2 2025Change
Revenue$88M$61M+43%
Gross profit$64M$40M+58%
Operating income$3.5M−$4.3Mto a profit
Net income$5.3M−$5.3Mto a profit
Diluted EPS$0.08−$0.24to a profit
Revenue by product, Q2 2026, as reported to the SEC
ProductRevenueShare
Service$81M92%
Hardware$7.1M8.1%

Business segments

Revenue split by product segment, from SEC XBRL filings.

Latest period: Jun 2026Total $87.8M (+13%)
Hardware grew +62% year on yearService +42% year on year
  • Service$80.7Mquarter on quarter +16%year on year +42%
  • Hardware$7.1Mquarter on quarter -16%year on year +62%
Segment sum = 100% of reported consolidated revenue · Latest source: 10-Q filed Aug 7, 2026, SEC EDGAR
On our screens:Most shorted stocks